Search
for
Sort by
Research 241–270 of 488
- Men??s Health
- National scientific medical meeting 1996 abstracts
- Vitamins
- Caffeine and Its Role in Regulation the Androgenetic Alopecia.
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- Hair loss
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Androgenisierung
- P-18 THREE BODY PROBLEM PATIENT: EHLER DANLOS SYNDROME COMBINED WITH HYPOPHOSPHATASIA AND FATTY ACID OXIDATION DEFECT
- Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring
- Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study
- Serious complication of low-dose oral minoxidil for hair loss
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- Living with long COVID and its impact on family and society: a couple's view
- Central retinal vein occlusion with secondary cilioretinal artery occlusion following oral minoxidil use: A case report and literature review
- P326: Cardiovascular features in adult individuals affected with Tatton-Brown-Rahman syndrome
- Severe and refractory hypotension after intentional minoxidil overdose: a case report
- Thrombophilia and Polycythemia in a Woman With Budd-Chiari Syndrome
- FRI549 The See-Saw Theory - Hypothyroidism Due To Hashimoto's Thyroiditis Followed By Hyperthyroidism Due To Graves' Disease
- Tangled
- This Week in JAMA
- ESCITALOPRAM
- Edema periorbitario matutino por minoxidil oral a dosis bajas
- Side effects of vitamins, amino acids, nutrition, and complementary and alternative medicine
- 1249
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Direct-Acting Vasodilators
- <i>De novo</i> mutation in the mitochondrial tRNA<sup>Leu(UUR)</sup> gene (A3243G) with rapid segregation resulting in MELAS in the offspring
- The Treatment of Resistant Hypertension